
Imascap SAS
Imascap, a leader in the development of software-based solutions for preoperative planning of shoulder replacement surgery.
Date | Investors | Amount | Round |
---|---|---|---|
$88.8m Valuation: $88.8m 55.1x EV/Revenue 306.9x EV/EBITDA | Acquisition | ||
Total Funding | 000k |
EUR | 2015 | 2016 | 2017 | 2020 | 2021 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 195 % | 52 % | - | 653 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (30 %) | 26 % | 18 % | (392 %) | 23 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (25 %) | 34 % | 40 % | (317 %) | 23 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Imascap SAS, established in 2009 by Jean Chaoui, is a company focused on developing advanced software for surgical planning, particularly in the field of orthopedics. The firm was founded by Jean Chaoui, whose background as a researcher in biomechanics at Arts et Métiers ParisTech heavily influenced the company's direction, aiming to bridge the gap between academic research and clinical application. This foundation in scientific research is a core element of the company's identity.
The company's primary offering is a suite of 3D digital software solutions that assist surgeons in pre-operative planning for shoulder arthroplasty. Its main products, including the Glenosys and Pelvisys platforms, allow surgeons to create patient-specific 3D models from CT scans. These models enable precise planning of implant placement and surgical approaches, aiming to improve surgical accuracy and patient outcomes. This technology serves orthopedic surgeons and medical device companies, providing them with tools for complex procedures.
Imascap's business model revolves around providing these software solutions and services to the medical field. The company was acquired by Wright Medical Group in 2017, a move that integrated Imascap's software into Wright's upper extremity product portfolio. This acquisition provided Imascap with a larger distribution network and resources, while Wright Medical gained a sophisticated pre-operative planning tool, which was later enhanced by the launch of their BLUEPRINT 3D planning software.
Keywords: surgical planning software, orthopedics, 3D modeling, shoulder arthroplasty, medical imaging, pre-operative planning, biomechanics, medical technology, digital surgery, patient-specific instruments